Droperidol
| Clinical data | |
|---|---|
| Pronunciation | /droʊˈpɛrIdɔːl/ | 
| Pregnancy category | 
 | 
| Routes of administration | Intravenous, Intramuscular | 
| Drug class | Typical antipsychotic | 
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Metabolism | Hepatic | 
| Elimination half-life | 2.3 hours | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.008.144 | 
| Chemical and physical data | |
| Formula | C22H22FN3O2 | 
| Molar mass | 379.435 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
Droperidol /droʊˈpɛrɪdɔːl/ (Inapsine, Droleptan, Dridol, Xomolix, Innovar [combination with fentanyl]) is an antidopaminergic drug used as an antiemetic (that is, to prevent or treat nausea) and as an antipsychotic. Droperidol is also often used as a rapid sedative in intensive-care treatment, and where "agitation aggression or violent behavior" are present.